Corporate / M&A

Regulatory

Competition

Aryzta

On March 12, 2021, ARYZTA AG (SWX: ARYN) announced that it has signed a definitive agreement to sell its North American business to Lindsay Goldberg LLC for a total enterprise value of USD 850 m.
The transaction is expected to complete by the end of ARYZTA’s current 2021 financial year and is subject to closing conditions customary for this type of transaction.
Homburger acted as Swiss counsel to ARYZTA in connection with the transaction. The Homburger team was led by partner Claude Lambert and comprised partner Andreas Müller and associates Marc Hanslin and Margrit Marti (all Corporate / M&amp;A), associate David Waldmeier (Competition, Regulatory) as well as junior associate Géraldine Danuser (Corporate / M&amp;A).

Homburger advises ARYZTA AG on disposal of its North American business to Lindsay Goldberg LLC

On March 16, 2021, the diversified industrial group Picanol NV (EBR: PIC) announced that it has acquired 10% of the share capital of Rieter Holding AG (SWX: RIEN), the world’s leading supplier of systems for short-staple fiber spinning, for an aggregate purchase price of EUR 45.4 m.
With the financial participation in Rieter, Picanol wants to further diversify its activities in the textile industry and secure a stable shareholding for Rieter in the long term.
Homburger acted as Swiss counsel to Picanol in connection with the transaction. The Homburger team comprised partner Dieter Gericke and associate Marc Hanslin (both Corporate / M&amp;A). Stibbe BV/SRL (Jan Peeters) acted as Belgian counsel to Picanol.

Homburger advised Picanol NV on its acquisition of a minority stake in Rieter Holding AG

On December 10, 2020, Boehringer Ingelheim announced the signing of a binding agreement on the acquisition of all shares in NBE-Therapeutics AG. The total transaction value is EUR 1.18 bn and includes contingent clinical and regulatory milestones.
NBE-Therapeutics, headquartered in Basel, Switzerland, is a private, clinical-stage Swiss biotechnology company focused on antibody-drug conjugates and advancing targeted cancer therapies derived from its immune stimulatory iADC™ platform.
Homburger acted as legal advisor to the seller PPF Group, an international investment group rooted in the Czech Republic. The Homburger team was led by partner Dieter Gericke (Corporate / M&amp;A) and comprised partner Reto Heuberger (Tax) and associate Marc Hanslin (Corporate / M&amp;A).

Marc
Hanslin

Homburger advises ARYZTA AG on disposal of its North American business to Lindsay Goldberg LLC

Homburger advised Picanol NV on its acquisition of a minority stake in Rieter Holding AG

Homburger advised PPF Group in the sale of NBE-Therapeutics to Boehringer Ingelheim

Investing In... 2021

Structuring Cross-border Transactions

Verantwortlichkeit des Verwaltungsrats für Konzerndarlehen - Besprechung der Urteils 4A_268/2018 des schweizerischen Bundesgerichts vom 18. November 2019

Join the Team

Marc Hanslin

Career

Languages

Bar Registration

Teams

MarcHanslin

Homburger advises ARYZTA AG on disposal of its North American business to Lindsay Goldberg LLC

Homburger advised Picanol NV on its acquisition of a minority stake in Rieter Holding AG

Homburger advised PPF Group in the sale of NBE-Therapeutics to Boehringer Ingelheim

Investing In... 2021

Structuring Cross-border Transactions

Verantwortlichkeit des Verwaltungsrats für Konzerndarlehen - Besprechung der Urteils 4A_268/2018 des schweizerischen Bundesgerichts vom 18. November 2019

Join the Team

Marc Hanslin

Career

Languages

Bar Registration

Teams

Marc
Hanslin